A specialty biopharmaceutical company focused on developing and commercializing drug delivery technologies, particularly transdermal patches and other controlled‑release formulations. Its portfolio has included treatments for central nervous system disorders such as ADHD, alongside partnerships with...
1 member of Congress has disclosed 4 trades in Corium International Inc (CORI), a Healthcare company. The buy/sell breakdown shows 2 purchases versus 2 sales. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2019-03-26 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2019-03-12 | MICHAEL T. MCCAUL | buy | $1K – $15K |
| 2017-08-29 | MICHAEL T. MCCAUL | sell | $1K – $15K |
| 2017-01-17 | MICHAEL T. MCCAUL | sell | $1K – $15K |